Investment

PYC Therapeutics Completes A$146 million Placement

PYC Therapeutics Ltd (ASX: PYC) is a clinical-stage biotechnology company that is involves int the creation of RNA therapies for patients with genetic diseases. They make use of their proprietary RNA therapeutic class drug delivery platform to enhance the potency of precision medicines. PYC focuses on three core therapeutic areas, ocular, central nervous and renal […]

22nd April 2025
Investment

PYC Therapeutics Gets Green Light for Human Trials of Groundbreaking PKD Drug Candidate

10th February 2025
Investment

PYC Therapeutics Advances Pre-Clinical PKD Therapy with PYC-003, Set for Clinical Trials in 2025

27th November 2024

REACH YOUR FULL POTENTIAL

Ready to elevate yourgame to new heights? Look no further!

By submitting your details below, you’ll gain exclusive access to the finest content in investment and lifestyle from KODARI Magazine. Whether you’re seeking insights into luxury living, expert investment insights, or the latest trends in high-end fashion and travel, we’ve got you covered.